Cost-Effectiveness of FOLFIRINOX for First-Line Treatment of Metastatic Pancreatic Cancer.
Journal of Clinical Oncology - United States
doi 10.1200/jco.2012.30.4_suppl.199
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2012
Authors
Publisher
American Society of Clinical Oncology (ASCO)